Covenant Multifamily Offices’s CareDx CDNA Stock Holding History

Covenant Multifamily Offices’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,000	Closed	-$32K	–	156
2019 Q1	$32K	Buy	+1,000	New	+$29.1K	0.01%	143

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Covenant Multifamily Offices's CDNA Position: Q2 2019 in Review

Covenant Multifamily Offices sold out of CareDx (CDNA) in Q2 2019, closing a stake of 1,000 shares — an estimated $32K sold.

Covenant Multifamily Offices first reported a position in CDNA in Q1 2019 and held it in 1 quarter. The position peaked at $32K in Q1 2019. 182 funds tracked by Wall St. Rank hold CDNA as of Q2 2019.

Covenant Multifamily Offices reported no remaining CareDx position as of Q2 2019 after selling out during the quarter.
Covenant Multifamily Offices sold 1,000 CareDx shares in Q2 2019, an estimated $32K.
Covenant Multifamily Offices first reported a position in CareDx in Q1 2019 and held it in 1 quarter.
Covenant Multifamily Offices's CareDx position peaked at $32K in Q1 2019.
182 funds tracked by Wall St. Rank held CareDx as of Q2 2019.

Based on Covenant Multifamily Offices's 13F filing for Q2 2019, filed 31 Jul 2019.